结构:Nc1ccnc2ccccc12
HCID68476

4-Aminoquinoline

quinolin-4-amine

C9H8N2144.17 g/molCAS 578-68-7

IDENTITY

结构与身份

标准 SMILES
Nc1ccnc2ccccc12
InChIKey
FQYRLEXKXQRZDH-UHFFFAOYSA-N
分子式
C9H8N2
平均分子量
144.17 g/mol
单同位素质量
144.06874826

COMPUTED

结构计算性质

已同步
XLogP
1.6
极性表面积
38.9 Ų
氢键供体
1
氢键受体
2
可旋转键
0
重原子
11
形式电荷
0
复杂度
136

GHS

GHS 分类

来源:PubChem
GHS Classification

Warning

H302 (93%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (11.6%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264, P264+P265, P270, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 43 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

HAZARDS

危害信息

来源:PubChem
Hazard Classes and Categories

Acute Tox. 4 (93%);Skin Irrit. 2 (11.6%);Eye Irrit. 2A (100%)

PHARMACOLOGY

药理信息

来源:PubChem
MeSH Pharmacological Classification

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)

ALIASES

名称与别名

60
4-Aminoquinoline578-68-74-QuinolinamineGTE5P5L97NDTXSID70206491RefChem:518302DTXCID70128982640-116-4quinolin-4-amine4-AminoguinolineQuinoline, 4-amino-MFCD004634484-quinolylamine139266-00-5Quinolin-4-ylamineCCRIS 1679UNII-GTE5P5L97N4(1H)-Quinolinimine(9CI)4-quinolinylamine4-amino quinoline

REACTIONS

参与反应

15
HRID935850

Validation data from https://doi.org/10.1039/C8SC04228D

作为反应物
HRID 935850 方程式

Validation data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D

查看条件与参与物
HRID941730

Validation data from https://doi.org/10.1039/C8SC04228D

作为反应物
HRID 941730 方程式

Validation data from https://doi.org/10.1039/C8SC04228D · 10.1039/C8SC04228D

查看条件与参与物
HRID1121798

Training data from https://doi.org/10.1039/C8SC04228D (7/10)

作为反应物
HRID 1121798 方程式

Training data from https://doi.org/10.1039/C8SC04228D (7/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID1231046

Training data from https://doi.org/10.1039/C8SC04228D (5/10)

作为反应物
HRID 1231046 方程式

Training data from https://doi.org/10.1039/C8SC04228D (5/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID1553806

Training data from https://doi.org/10.1039/C8SC04228D (1/10)

作为反应物
HRID 1553806 方程式

Training data from https://doi.org/10.1039/C8SC04228D (1/10) · 10.1039/C8SC04228D

查看条件与参与物